The 2-stage Approach for Reducing Posterior Wall Puncture During the Internal Jugular Vein Catheterization

NCT ID: NCT01026649

Last Updated: 2016-04-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

334 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the effect of a 2-stage approach to the internal jugular vein when performing a central venous catheterization compared to the traditional one stage approach on the incidence of hematoma formation and success rate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2 stage

Approach the internal jugular vein in a 2 stage fashion during central venous catheterization

Group Type EXPERIMENTAL

Central venous catheterization

Intervention Type PROCEDURE

Approach the internal jugular vein in a 2 stage fashion during central venous catheterization

1 stage

Approach the internal jugular vein in a traditional one stage fashion during central venous catheterization

Group Type ACTIVE_COMPARATOR

Central venous catheterization

Intervention Type PROCEDURE

Approach the internal jugular vein in a traditional one stage fashion during central venous catheterization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Central venous catheterization

Approach the internal jugular vein in a traditional one stage fashion during central venous catheterization

Intervention Type PROCEDURE

Central venous catheterization

Approach the internal jugular vein in a 2 stage fashion during central venous catheterization

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who require a central venous catheter for their thoracic surgery

Exclusion Criteria

* Refuse to enroll
* Infection at insertion site
* Carotid artery disease
* Anomaly of central vasculature
* Hypertrophied thyroid
* History of recent neck surgery
Minimum Eligible Age

19 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jae-Hyon Bahk, MD, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, Seoul, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JHBahk_CVC two stage

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.